Best Practice & Research Clinical Rheumatology
Volume 22, Issue 2 , Pages 339-350 , April 2008

Musculoskeletal involvement in systemic sclerosis

References 

  1. Schumacher HR. The joint involvement in systemic sclerosis. Clinics in Dermatology. 1994;12:277–282
  2. Rodnan GP. The nature of joint involvement in progessive systemic sclerosis (diffuse scleroderma). Annals of Internal Medicine. 1962;56:422–429
  3. Rodnan GP, Medsger TAJ. Musculoskeltal involvement in progessive systemic sclerosis (scleroderma). Bulletin on the Rheumatic Diseases. 1966;17:419
  4. Tuffanelli DL, Winkelmann RK. Systemic scleroderma: a clinical study of 727 cases. Archives of Dermatology. 1961;84:359–371
  5. Pope JE. Musculoskeletal involvement in scleroderma. Rheumatic Diseases Clinics of North America. 2003;29:391–408
  6. Blocka K, Bassett LW, Furst DE, et al. The arthropaty of advanced of progressive systemic sclerosis. Arthritis and Rheumatism. 1981;24:874–884
  7. Casale R, Buonocore M, Matucci Cerinic M. Systemic sclerosis (Scleroderma): an integrated challenge in rehabilitation. Archives of Physical Medicine and Rehabilitation. 1997;78:762–773
  8. Medsger TA, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Annals of Internal Medicine. 1971;74:714–721
  9. Baron M, Lee P, Keistone EC. The articular manifestation of systemic sclerosis (scleroderma). Annals of the Rheumatic Diseases. 1982;41:147–152
  10. La Montagna G, Sodano A, Capurro V, et al. The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiology. 2004;
  11. Malesci D, La Montagna G, Valentini G. The arthropathy of systemic sclerosis. Rheumatism. 2005;57:232–237
  12. Medsger TA, Bombardieri S, Czirjak L, et al. Assessment of disease severity and prognosis. Clinical and Experimental Rheumatology. 2003;21:542–546
  13. Boutry N, Hachulla E, Zanetti-Musielak C, et al. Imaging features of musculoskeletal involvement in systemic sclerosis. European Radiology. 2007;17:1172–1180
  14. Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis and Rheumatism. 1978;21:62–71
  15. Resnick D. Scleroderma (progressive systemic sclerosis). Diagnosis of bone and joint disorders. 3rd edn.. Philadelphia: Saunders; 1995;pp. 1191–1217
  16. Jimenez SA, Derk C. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Annals of Internal Medicine. 2004;140:37–50
  17. Medsger TA, Rodnan GP, Moosy J, et al. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis and Rheumatism. 1968;11:554–568
  18. Thompson JM, Bluestone R, Bywaters EGL, et al. Skeletal muscle involvement in systemic sclerosis. Annals of the Rheumatic Diseases. 1969;28:281–288
  19. Akesson A, Fiori G, Krieg T, et al. Assessment of skin, joint, tendon and muscle involvement. Clinical and Experimental Rheumatology. 2003;21:S5–S8
  20. Medsger TA. Progressive systemic sclerosis: skeletal muscle involvement. Clinics in Rheumatic Diseases. 1979;5:103–113
  21. Follansbee W, Zerbe T, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. American Heart Journal. 1993;125:194–203
  22. West SG, Killan PJ, Lawless OJ. Association of myositis and myocarditis in progressive systemic sclerosis. Arthritis and Rheumatism. 1981;24:662–667
  23. Mimura Y, Ihn H, Jinnin M, Asano Y, et al. Clinical and laboratory features of scleroderma patients developing skeletal myopahy. Clinical Rheumatology. 2005;24:99–102
  24. Brun B, Serup J, Hagdrup H. Radiological changes of the hands in systemic sclerosis. Acta Dermato-Venereologica. 1983;63:349
  25. Avouac J, Guerini H, Wipff J, et al. Radiological hand involvement in systemic sclerosis. Annals of the Rheumatic Diseases. 2006;65:1088–1092
  26. Lovell CR, Jayson MIV. Joint involvement in systemic sclerosis. Scandinavian Journal of Rheumatology. 1979;8:154–160
  27. Forget CP. Mémoire sur le chorionitis ou la sclerostenose cutanée (maladie non décrit par les auteurs). Gaz Med Strasbourg. 1847;7:200–212
  28. Osler W. On diffuse scleroderma: with special reference to diagnosis and the use of thyroid gland extract. Journal of Cutaneous and Genito-Urinary Diseases. 1898;16:49–67
  29. Jablonska S, Bubnow B, Lukasiak B. Acrosclerosis: a disease sui generis or a variety of diffuse scleroderma?. British Journal of Rheumatology. 1959;71:123–133
  30. Ostojic P, Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clinical Rheumatology. 2006;25:453–457
  31. Schumacher HR. Joint involvement in progressive systemic sclerosis (scleroderma): a light and electron microscopic study of synovial membrane and fluid. American Journal of Clinical Pathology. 1973;60:593–600
  32. Rodnan GP, Medsger TA. The rheumatic manifestation of progressive systemic sclerosis (slceroderma). Clinical Ortopaedics and Related Research. 1968;57:81–93
  33. Clarke MD, Winkelman RK, McDuffe FC. Synovial tissue changes and rheumatoid factor in scleorderma. Mayo Clinic Proceedings. 1971;46:97–101
  34. Brower LM, Poole JL. Reliability and validity of the Duruoz Hand index in person wth systemic sclerosis (scleroderma). Arthritis and Rheumatism. 2004;51:805–809
  35. Westphal C. Zwei Falle Von Schlerodermie. Chariete Annalen. 1876;3:341–360
  36. Harley J. A case of simple atrophic scleroma associated with disorder of the circulatory and pigmentary functions. Medico-Surgical Trans. 1877;60:131–137
  37. Shulman LE, Kurban AK, Harvey AM. Tendond friction rubs in progressive systemic sclerosis (sleroderma). Transaction of the Association of American Physician. 1961;74:378–388
  38. Steen VD, Medsger TA. The palpable tendon friction rub. Arthritis and Rheumatism. 1997;40:1146–1151
  39. La Montagna G, D'Angelo S, Valentini G. Cross-sectional evaluation of YKL-40 serum concentrations in patients with systemic sclerosis. Relationship with clinical and serological aspects of disease. The Journal of Rheumatology. 2003;10:2147–2151
  40. Radic M, Martinovic Kaliterna D, Ljutic D. The level of anti-topoisomerase I antibodies highly correlates with metacarppphalangeal and proximal interphalangeal joint flexion contractures in patients with systemic sclerosis. Clinical and Experimental Rheumatology. 2006;4:407–412
  41. Takahashi M, Okada J, Kondo H. Six cases positive for anti-centromere antibodies with ulcer and gagrene in the extremities. British Journal of Rheumatology. 1997;36:889–893
  42. Franceschini F, Cavazzana I, Generali D, et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. The Journal of Rheumatology. 2002;7:1393–1397
  43. Rozman B, Cucnik S, Sodin-Semrl S, et al. Prevalence and clinical associations of anti-KU antibodies in patients with systemic sclerosis: a European Eustar – initiated multicentre case control study. Annals of the Rheumatic Diseases, in press.
  44. Alkassab F. Overlap of systemic sclerosis an rheumatoid arthritis. The Journal of Rheumatology. 2007;34(7):1593–1594
  45. Kellgren JH, Ball J. Clinical significance of the rheumatoid serum factor. British Medical Journal. 1959;1:523
  46. Horiki T, Moriuchi J, Takaya M, et al. The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis and Rheumatism. 1996;39:152–156
  47. Schellekens GA, Visser H, De Jong BAW, et al. The diagnostic proprieties of rheumatoid arthritis antibodies recgnizing a cyclic citrullinated peptide. Arthritis and Rheumatism. 2000;43:155–163
  48. Marrone M, Chialà A, Tampoia M, et al. Prevalence of anti-CCP antibodies in systemic sclerosis. Rheumatism. 2007;59:20–24
  49. Catoggio LJ, Evison G, Harkness JA, Maddison PJ. The arthropaty of systemic sclerosis (scleroderma): comparison with mixed connective tissue disease. Clinical and Experimental Rheumatology. 1983;1:101–112
  50. Misra R, Darton K, Jewkes RF, et al. Arthritis in scleroderma. British Journal of Rheumatology. 1995;34:831–837

PII: S1521-6942(08)00011-9

doi: 10.1016/j.berh.2008.01.008

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 2 , Pages 339-350 , April 2008

Article Tools

* Image Usage & Resolution